Martin F. Schacker
Chief Executive Officer at Tetragenex Pharmaceuticals, Inc.
Martin F. Schacker active positions
| Companies | Position | Start | End |
|---|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Chief Executive Officer | 2010-02-04 | - |
| Chairman | 2010-02-04 | - |
Career history of Martin F. Schacker
Former positions of Martin F. Schacker
| Companies | Position | Start | End |
|---|---|---|---|
| M.S. Farrell & Co., Inc. | Chairman | 2001-02-01 | 2001-02-01 |
| President | - | 2001-02-01 | |
| D.H. Blair & Co. | Corporate Officer/Principal | 1991-12-01 | 1991-12-01 |
Lehman Brothers Holdings Plc
 Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Corporate Officer/Principal | 1987-05-01 | 1987-05-01 |
Training of Martin F. Schacker
| Hofstra University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Chairman | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
| M.S. Farrell & Co., Inc. | |
Lehman Brothers Holdings Plc
Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK. | Finance |
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| D.H. Blair & Co. |
- Stock Market
- Insiders
- Martin F. Schacker
- Experience
